R. LOWRY DOBSON; JOHN C. WEAVER; LEON LEWIS, F.A.C.P.
This content is PDF only. Please click on the PDF icon to access.
Although beryllium and its compounds have been recognized as serious industrial hazards for only a decade, the available information concerning toxic manifestations in man and experimental animals has already become extensive. The first patient with a diffuse pulmonary granulomatosis later shown to have been due to beryllium was observed during 1941 at the Essex Sanatorium in Middleton, Massachusetts.1 Following recognition of the clinical entity, many controversies arose concerning the rôle of beryllium as an etiologic agent as opposed to that of the electronegative ions of beryllium salts. The experimental investigation of poisoning due to this metal has been characterized by
DOBSON RL, WEAVER JC, LEWIS L. BERYLLIUM GRANULOMATOSIS COMPLICATED BY TUBERCULOSIS: REPORT OF A CASE TREATED WITH ACTH*. Ann Intern Med. 1953;38:312–325. doi: https://doi.org/10.7326/0003-4819-38-2-312
Download citation file:
Published: Ann Intern Med. 1953;38(2):312-325.
Infectious Disease, Mycobacterial Infections.
Results provided by:
Copyright © 2020 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use